These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2215543)

  • 41. Rational approach to the quantification of genotoxicity.
    Benigni R
    Environ Mol Mutagen; 1992; 19(1):83-9. PubMed ID: 1732108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural basis of carcinogenicity in rodents of genotoxicants and non-genotoxicants.
    Rosenkranz HS; Klopman G
    Mutat Res; 1990 Feb; 228(2):105-24. PubMed ID: 2300064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Which rules for assembling short-term test batteries to predict carcinogenicity?
    Benigni R; Giuliani A
    Mol Toxicol; 1987; 1(2-3):143-66. PubMed ID: 3449755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic toxicology: can we design predictive in vivo assays?
    Clive D
    Mutat Res; 1988; 205(1-4):313-30. PubMed ID: 3285193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The carcinogenicity prediction and battery selection (CPBS) method: a Bayesian approach.
    Chankong V; Haimes YY; Rosenkranz HS; Pet-Edwards J
    Mutat Res; 1985 May; 153(3):135-66. PubMed ID: 3990699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of the carcinogenicity prediction and battery selection (CPBS) method to the Gene-Tox data base.
    Pet-Edwards J; Chankong V; Rosenkranz HS; Haimes YY
    Mutat Res; 1985 May; 153(3):187-200. PubMed ID: 3990701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Invited contribution: an objective approach to the development of short-term tests predictive of carcinogenicity.
    Rosenkranz HS; Ennever FK; Chankong V; Pet-Edwards J; Haimes YY
    Cell Biol Toxicol; 1986 Dec; 2(4):425-40. PubMed ID: 3077082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP.
    Ashby J; Tennant RW
    Mutat Res; 1991 May; 257(3):229-306. PubMed ID: 1707500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assembly and preliminary analysis of a genotoxicity data base for predicting carcinogens.
    Palajda M; Rosenkranz HS
    Mutat Res; 1985 May; 153(3):79-134. PubMed ID: 3887150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro testing for cancer-causing chemicals.
    McCann J
    Hosp Pract (Off Ed); 1983 Sep; 18(9):73-85. PubMed ID: 6411600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carcinogenesis. Testing times for the tests.
    Hay A
    Nature; 1991 Apr; 350(6319):555-6. PubMed ID: 2017254
    [No Abstract]   [Full Text] [Related]  

  • 52. Predictive assay for rodent carcinogenicity using in vivo biochemical parameters: operational characteristics and complementarity.
    Kitchin KT; Brown JL; Kulkarni AP
    Mutat Res; 1992 Apr; 266(2):253-72. PubMed ID: 1373835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
    Kirkland D; Reeve L; Gatehouse D; Vanparys P
    Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A reexamination of the low prevalence of carcinogens in an early carcinogen screen.
    McGregor DB; Pangrekar J; Rosenkranz HS; Klopman G
    Regul Toxicol Pharmacol; 1994 Feb; 19(1):97-105. PubMed ID: 8159818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. International Commission for Protection Against Environmental Mutagens and Carcinogens. A method for comparing and combining short-term genotoxicity test data: results and interpretation.
    Mendelsohn ML; Moore DH; Lohman PH
    Mutat Res; 1992 Mar; 266(1):43-60. PubMed ID: 1372963
    [No Abstract]   [Full Text] [Related]  

  • 58. Structure-activity relationship analysis tools: validation and applicability in predicting carcinogens.
    Mayer J; Cheeseman MA; Twaroski ML
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):50-8. PubMed ID: 18023949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carcinogenicity of medicinal drugs: a survey of IARC monographs.
    Török G; Csík M; Pintér A; Surján A
    Cent Eur J Public Health; 2000 Jul; 8 Suppl():83-5. PubMed ID: 10943485
    [No Abstract]   [Full Text] [Related]  

  • 60. The influence of the proportion of carcinogens on the cost-effectiveness of short-term tests.
    Ennever FK; Rosenkranz HS
    Mutat Res; 1988 Jan; 197(1):1-13. PubMed ID: 3122033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.